Topic: Alex Jones 2028

Alex Jones calls into the show while in transit to provide an update on his legal proceedings and to congratulate the truck winners. The conversation then shifts to the political climate in Michigan, with guests predicting a significant red shift in the state for the 2026 and 2028 elections. They note that being a conservative is no longer considered "taboo" in many communities.

A caller and the host discuss the shifting boundaries of political correctness, claiming that certain "forbidden" words are becoming socially acceptable again in the "truth movement." They offer a harsh critique of Speaker Mike Johnson, mocking his appearance and "Warby Parker glasses." The caller also mentions the popularity of "Alex Jones 2028" t-shirts and the possibility of Jones running for political office.

The host concludes the broadcast by discussing the creation of a backup network to ensure the continuation of his work despite legal attempts to shut down InfoWars. Listeners are directed to RealAlexJones.com for merchandise and supplements, including a "Trump 2028" hat and "Save the Frogs" plushies. The show ends with a call to fund the "second American revolution" through continued support of the platform.

Alex Jones discusses a documentary regarding a government war game simulation titled SPARS 2025-2028, which he claims mirrors the current COVID-19 pandemic response. Former National Security Advisor Michael Flynn endorsed the report, suggesting the simulation serves as an operational manual for globalist agendas. The discussion highlights parallels between the simulation's scripted social media posts and real-world events from 2020 and 2021.

Alex Jones introduces an emergency transmission regarding the SPARS 2025-2028 document from Johns Hopkins. The discussion asserts that this document, along with Event 201 and Operation Lockstep, serves as a blueprint for a scientific dictatorship and a planned takeover. Jones claims that Anthony Fauci and Bill Gates are utilizing these simulations to mask real-world operations involving gain-of-function research and experimental gene therapies.